Anpario (LON:ANP) Earns House Stock Rating from Shore Capital

Anpario (LON:ANP)‘s stock had its “house stock” rating restated by Shore Capital in a report issued on Wednesday, Marketbeat.com reports.

Anpario Price Performance

Anpario stock opened at GBX 497.40 on Wednesday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 5.16 and a current ratio of 6.15. The firm has a market cap of £84.29 million, a P/E ratio of 2,036.86 and a beta of 0.58. The business’s fifty day moving average is GBX 406.79 and its two-hundred day moving average is GBX 413.80. Anpario has a 52 week low of GBX 286 and a 52 week high of GBX 510.

Anpario (LON:ANP) last posted its quarterly earnings data on Wednesday, September 10th. The company reported GBX 16.87 EPS for the quarter. Anpario had a return on equity of 8.74% and a net margin of 9.23%. Equities research analysts forecast that Anpario will post 23.5757801 earnings per share for the current fiscal year.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.